心血管

订阅

MedSci主页 / 所有栏目 / 心血管

JAHA：冠心病发病率竟与出生地有关？！

2018-03-29 MedSci MedSci原创

心血管冠心病卒中
关注

在国外出生的美国成年人的比例逐年增加，然而心血管疾病的发生是否与出生地点相关仍属未知。本研究的目的旨在评估比较不同地方出生的美国人的冠心病（CHD）和卒中发病率。本研究纳入了2006年至2014年国家健康调查的数据，将出生地分成美国和其他国家，其他国家又分成6大地区。分析结果发现，在美国的成年人中，16%是在其他国家出生的，与出生在其他国家的成年人相比，出生在美国的年龄标准化后的CHD发病率和卒中

在国外出生的美国成年人的比例逐年增加，然而心血管疾病的发生是否与出生地点相关仍属未知。本研究的目的旨在评估比较不同地方出生的美国人的冠心病（CHD）和卒中发病率。本研究纳入了2006年至2014年国家健康调查的数据，将出生地分成美国和其他国家，其他国家又分成6大地区。分析结果发现，在美国的成年人中，16%是在其他国家出生的，与出生在其他国家的成年人相比，出生在美国的年龄标准化后的CHD发病率和卒中发病率均明显更高（p<0.05），进一步分析不同地区出生的数据，发现CHD的发病率在亚洲、墨西哥、中美洲或加勒比海出生的最低，男性的卒中发病率在南美或者非洲出生的最低，女性卒中发病率在欧洲出生的最低。此外，在美国生活的年数不与CHD和卒中的发病相关。研究结果显示，在其他国家地区出生的成年人的冠心病和卒中发病率要低于在美国出生的。原始出处：Jing F et al.Association of Birthplace and Coronary Heart Disease and Stroke Among US Adults: National Health Interview Survey,

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1823447, encodeId=c97e182344e7c, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Sep 01 01:30:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302647, encodeId=1f7230264eda, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 04 09:08:02 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301676, encodeId=ddfc3016e692, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 01 08:32:31 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267780, encodeId=ef78126e78049, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 31 10:30:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301143, encodeId=d57330114330, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Mar 30 08:37:25 CST 2018, time=2018-03-30, status=1, ipAttribution=)]
    2018-09-01 lifestar

    #发病率#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1823447, encodeId=c97e182344e7c, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Sep 01 01:30:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302647, encodeId=1f7230264eda, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 04 09:08:02 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301676, encodeId=ddfc3016e692, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 01 08:32:31 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267780, encodeId=ef78126e78049, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 31 10:30:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301143, encodeId=d57330114330, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Mar 30 08:37:25 CST 2018, time=2018-03-30, status=1, ipAttribution=)]
    2018-04-04 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1823447, encodeId=c97e182344e7c, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Sep 01 01:30:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302647, encodeId=1f7230264eda, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 04 09:08:02 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301676, encodeId=ddfc3016e692, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 01 08:32:31 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267780, encodeId=ef78126e78049, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 31 10:30:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301143, encodeId=d57330114330, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Mar 30 08:37:25 CST 2018, time=2018-03-30, status=1, ipAttribution=)]
    2018-04-01 yfjms

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1823447, encodeId=c97e182344e7c, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Sep 01 01:30:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302647, encodeId=1f7230264eda, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 04 09:08:02 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301676, encodeId=ddfc3016e692, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 01 08:32:31 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267780, encodeId=ef78126e78049, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 31 10:30:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301143, encodeId=d57330114330, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Mar 30 08:37:25 CST 2018, time=2018-03-30, status=1, ipAttribution=)]
    2018-03-31 zhaohui6731

    #AHA#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1823447, encodeId=c97e182344e7c, content=<a href='/topic/show?id=b2873e9220e' target=_blank style='color:#2F92EE;'>#发病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37922, encryptionId=b2873e9220e, topicName=发病率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Sat Sep 01 01:30:00 CST 2018, time=2018-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=302647, encodeId=1f7230264eda, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 04 09:08:02 CST 2018, time=2018-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301676, encodeId=ddfc3016e692, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 01 08:32:31 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267780, encodeId=ef78126e78049, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Mar 31 10:30:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=301143, encodeId=d57330114330, content=学习谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Fri Mar 30 08:37:25 CST 2018, time=2018-03-30, status=1, ipAttribution=)]
    2018-03-30 龙胆草

    学习谢谢分享

    0

相关资讯

JACC：收缩压与急性主动脉夹层患者死亡率明显相关

收缩压（SBP）在许多心血管疾病中是一个预测患者死亡风险的有力工具。本研究的目的旨在评估SBP在预测急性主动脉夹层（AAD）患者的院内预后尤其是全因死亡率方面的作用。本研究纳入了数据库中6238名AAD患者（4167名患者为A型AAD，2071名为B型AAD），并根据患者的SBP分成4组：SBP >150， SBP 101 - 150， SBP 81 - 100和SBP ≤80 mm Hg。

Diabetes Care：收缩压对2型糖尿病患者心血管结局的影响！

由此可见，该研究结果支持将收缩压的治疗目标值设为140mmHg，并且怀疑无并发症的2型糖尿病患者更低的收缩压目标值（＜120或130mmHg）CVD风险会降低。还需要一个随机对照试验来证实这些发现。

NEJM：非布司他或别嘌呤醇对痛风患者的心血管安全性分析！

由此可见，对于痛风合并主要心血管的患者，非布索坦的不良心血管事件发生率并不逊于别嘌呤醇。但是非布索坦的全因死亡率和心血管死亡率高于别嘌呤醇。

Am J Respir Crit Care Med：REM睡眠期间严重睡眠呼吸暂停可发生急性心血管事件

3月1日，在线发表于《American Journal of Respiratory and Critical Care Medicine》杂志上的一项研究显示，曾经发生过心血管疾病的患者如果在快速眼动（REM）睡眠期出现重度阻塞性睡眠呼吸暂停（OSA）将会使其心血管疾病复发风险进一步升高。

JACC：外科主动脉瓣置换术的远期预后研究

本研究的目的旨在评估接受外科主动脉瓣置换术（SAVR）患者的远期临床预后和瓣膜的结构退化（SVD）情况。本研究纳入了2002年至2004年接受SAVR治疗的672名（平均年龄72 ± 8岁，男性占61.5%）患者，其中对624名术后出院的患者进行了心超检查，在术后随访10年后对209名患者进行了心超检查。经过平均10年时间的随访，432名（64.3%）患者出现了死亡。高龄、左室功能不良、房颤、慢性

JACC：传统外科生物瓣膜置换术 vs 快速瓣膜释放术

目前，对于主动脉瓣疾病的患者，外科的传统生物瓣膜置换（CBVs）手术是治疗的标准，但是近期也出现了新式的快速释放瓣膜（RDVs）手术。本研究的目的旨在评估和比较RDVs和CBVs在治疗主动脉瓣狭窄患者中的疗效。本研究纳入了数据库中2011年至2015年接受外科主动脉瓣置换术（RDVs或者CBVs）的22062名患者，并通过1：1的倾向评分匹配比较了RDVs和CBVs患者的各类参数。最终共有2093